CN Stock MarketDetailed Quotes

600332 Guangzhou Baiyunshan Pharmaceutical Holdings

Watchlist
  • 31.72
  • -0.10-0.31%
Trading May 23 10:59 CST
51.57BMarket Cap12.56P/E (TTM)

Guangzhou Baiyunshan Pharmaceutical Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guangzhou Baiyunshan Pharmaceutical Holdings Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

22.95B

+6.09%
EPS(YoY)

1.20

+2.56%
Analyst Rating

Strong Buy

May 22, 2024

Guangzhou Baiyunshan Pharmaceutical Holdings Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 19.489B--
--2024/Q2-- / 19.626B--
--2024/Q122.946B / 23.143B--
--2023/Q417.331B / 17.382B--
Oct 31, 20232023/Q318.214B / 19.125B--
Aug 19, 20232023/Q218.342B / 18.143B--
Oct 29, 20202020/Q316.415B / 18.728B--
Aug 26, 20202020/Q213.485B / 16.229B--
Apr 29, 20202020/Q116.985B / 18.354B--
--2019/Q414.889B / 11.209B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 19.489B--
--2024/Q2-- / 19.626B--
--2024/Q122.946B / 23.143B--
--2023/Q417.331B / 17.382B--
Oct 31, 20232023/Q318.214B / 19.125B--
Aug 19, 20232023/Q218.342B / 18.143B--
Oct 29, 20202020/Q316.415B / 18.728B--
Aug 26, 20202020/Q213.485B / 16.229B--
Apr 29, 20202020/Q116.985B / 18.354B--
--2019/Q414.889B / 11.209B--

Unlock Free Earnings Estimates

Guangzhou Baiyunshan Pharmaceutical Holdings Earnings Reports

  • Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. 2024 First Quarter Report

    Apr 26 12:00 ET

  • Supplementary Announcement of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. on the 2023 Annual Report

    Mar 22 12:00 ET

  • Full text of the 2023 Annual Report of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (revised edition)

    Mar 22 12:00 ET

  • Summary of the 2023 Annual Report of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd.

    Mar 15 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 22, 2024

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg